Table 3 Baseline demographic data of study population group by AKI
Clinical features | Without AKI(n = 3338) | With AKI(n = 204) | P |
|---|---|---|---|
Age (years) | 45.29 ± 9.56 | 45.06 ± 9.59 | 0.63 |
BMI | 22.64 ± 6.22 | 22.18 ± 3.46 | 0.15 |
eGFR | 100.28 ± 18.88 | 77.61 ± 37.41 | < 0.001 |
Alcohol consumption | 40 (1.20%) | 2 (0.98%) | 0.78 |
Anemia | 649 (19.44%) | 58 (28.43%) | 0.002 |
Hypertension | 705 (21.12%) | 66 (32.35%) | < 0.001 |
Diabetes mellitus | 166 (4.97%) | 17 (8.33%) | 0.03 |
ACEI | 58 (1.74%) | 4 (1.96%) | 0.81 |
ARB | 33 (0.99%) | 3 (1.47%) | 0.50 |
CCB | 417 (12.44%) | 37 (18.14%) | 0.02 |
Diuretics | 33 (0.99%) | 6 (2.94%) | 0.01 |
ASA grade | < 0.001 | ||
I–II | 2704 (81.01%) | 144 (70.59%) | |
III–V | 634 (18.99%) | 60 (29.41%) | |
Operative time (min) | 0.004 | ||
≤ 60 | 446 (13.36%) | 23 (11.27%) | |
61–120 | 882 (26.42%) | 34 (16.67%) | |
121–180 | 852 (25.52%) | 58 (28.43%) | |
> 180 | 1158 (34.69%) | 89 (43.63%) | |
Intraoperative erythrocyte Transfusion, mL (%) | 0.004 | ||
< 100 | 2596 (77.77%) | 137 (67.16%) | |
100–600 | 353 (10.58%) | 31 (15.20%) | |
601–1000 | 181 (5.42%) | 14 (6.86%) | |
> 1000 | 208 (6.23%) | 22 (10.78%) | |
Intraoperative Hemorrhage, mL (%) | 0.12 | ||
< 100 | 1054 (31. 58%) | 57 (27.94%) | |
100–600 | 1824 (54.64%) | 109 (53.43%) | |
601–1000 | 240 (7.19%) | 22 (10.78%) | |
> 1000 | 220 (6.59%) | 16 (7.84%) | |
In fluid amount (10 mL/24 h) | 937.50 (625.00–1375.00) | 1135.42 (729.17–1526.04) | < 0.001 |
Out fluids amount (10 mL/24 h) | 312.50(145.83–541.67) | 333.33 (187.50–625.00) | 0.02 |
Intraoperative hypotension | 363(10.87%) | 29(14.21%) | 0.005 |
Parecoxib | 332 (9.95%) | 12 (5.88%) | 0.05 |
Admission to ICU | 90 (2.70%) | 8 (3.92%) | 0.30 |
Death | 7 (0.21%) | 4 (1.96%) | < 0.001 |